Evaluation of the effect of autologous hematopoietic stem cell transplant on symptom severity using MSWS-12, AMSQ and symptomscreen in multiple sclerosis patients

Key Points

• Symptom severity decreased in multiple sclerosis patients after transplant, indicating better management of the disease.
• The evaluation utilized msws-12, amsq, and symptomscreen to assess subjective symptom changes.
• Observational analysis included patients undergoing autologous hematopoietic stem cell transplant, focusing on symptom reduction.
• Findings suggest that autologous stem cell therapy may improve quality of life and symptom control within this population.